• AstraZeneca and Sanofi's antibody prevents RSV in phase 3, accelerating path to market

    15 days ago - By Fierce Biotech

    AstraZeneca and Sanofi's antibody prevents RSV in phase 3, accelerating path to market ntaylor
    Mon, 04/26/2021 - 04:58
    Read more ...